At Neurocrine Biosciences, our purpose is simple: to relieve suffering for people with great needs, but few options.
Through internal investment and external collaboration, Neurocrine Biosciences relentlessly pursues scientific discovery and partnerships that can lead to important therapies for patients.
Neurocrine Biosciences is currently enrolling patients in clinical trials for products across our therapeutic areas.
Neurocrine Biosciences is committed to raising awareness for people living with tardive dyskinesia (TD), a condition in which people taking certain mental health medicines experience uncontrollable movements in different parts of their bodies. We are dedicated to the recognition of the first week of May (1-7) as TD Awareness Week (TDAW) to increase awareness and support for all those living with TD.
Our management team participates in industry conferences, presenting company updates and progress on research and development activities.
Our employees are our most valuable assets. No matter an individual’s role, level, or time with Neurocrine Biosciences, each person plays an important part in not only making a difference for patients, but also creating a great place to work.
Our culture emphasizes collaboration and innovation as core values. Neurocrine Biosciences thrives as a company when we embrace unique ideas and a range of perspectives.
